APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immobilized Lipase

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Immobilized Lipase Market Outlook and Growth Opportunities 2026

20 December 2025192 pages

Choose your research edition.

Industry ResearchImmobilized Lipase Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Immobilized Lipase Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Immobilized Lipase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immobilized Lipase Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Immobilized Lipase Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Immobilized Lipase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Immobilized Lipase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immobilized Lipase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immobilized Lipase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Immobilized Lipase market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Immobilized Lipase market include Syncozymes, Yili Chuannig Biotechnology, Amicogen, ChiralVision, Novozymes, Beijing Global Biologicals and Qingdao Weilan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Immobilized Lipase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immobilized Lipase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immobilized Lipase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immobilized Lipase market size, projected growth trends, production technologies, key applications, and end-use industries.

Immobilized Lipase Segment by Company

Syncozymes

Yili Chuannig Biotechnology

Amicogen

ChiralVision

Novozymes

Beijing Global Biologicals

Qingdao Weilan Bio

Immobilized Lipase Segment by Type

Encapsulation

Covalent Bonding

Adsorption

Cross-linking

Immobilized Lipase Segment by Application

Pharmaceuticals

Food

Chemicals

Others

Immobilized Lipase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Immobilized Lipase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Immobilized Lipase market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Immobilized Lipase significant trends, drivers, influence factors in global and regions.

6. To analyze Immobilized Lipase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immobilized Lipase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immobilized Lipase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immobilized Lipase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immobilized Lipase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immobilized Lipase industry.

Chapter 3: Detailed analysis of Immobilized Lipase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Immobilized Lipase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Immobilized Lipase in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Immobilized Lipase Industry Trends Table 2. Immobilized Lipase Industry Drivers Table 3. Immobilized Lipase Industry Opportunities and Challenges Table 4. Immobilized Lipase Industry Restraints Table 5. Global Immobilized Lipase Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Immobilized Lipase Revenue Share by Company (2021-2026) Table 7. Global Immobilized Lipase Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Immobilized Lipase Sales Volume Share by Company (2021-2026) Table 9. Global Immobilized Lipase Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Immobilized Lipase Company Ranking, (2024-2026) & (USD Million) Table 11. Global Immobilized Lipase Key Company Manufacturing Base & Headquarters Table 12. Global Immobilized Lipase Company, Product Type & Application Table 13. Global Immobilized Lipase Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Immobilized Lipase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Encapsulation Table 18. Significant Companies of Covalent Bonding Table 19. Significant Companies of Adsorption Table 20. Significant Companies of Cross-linking Table 21. Global Immobilized Lipase Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 22. Global Immobilized Lipase Sales Volume by Type (2021-2026) & (Tons) Table 23. Global Immobilized Lipase Sales Volume by Type (2027-2032) & (Tons) Table 24. Global Immobilized Lipase Sales Volume Share by Type (2021-2026) Table 25. Global Immobilized Lipase Sales Volume Share by Type (2027-2032) Table 26. Global Immobilized Lipase Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Immobilized Lipase Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Immobilized Lipase Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Immobilized Lipase Sales Value Share by Type (2021-2026) Table 30. Global Immobilized Lipase Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pharmaceuticals Table 32. Significant Companies of Food Table 33. Significant Companies of Chemicals Table 34. Significant Companies of Others Table 35. Global Immobilized Lipase Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 36. Global Immobilized Lipase Sales Volume by Application (2021-2026) & (Tons) Table 37. Global Immobilized Lipase Sales Volume by Application (2027-2032) & (Tons) Table 38. Global Immobilized Lipase Sales Volume Share by Application (2021-2026) Table 39. Global Immobilized Lipase Sales Volume Share by Application (2027-2032) Table 40. Global Immobilized Lipase Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Immobilized Lipase Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Immobilized Lipase Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Immobilized Lipase Sales Value Share by Application (2021-2026) Table 44. Global Immobilized Lipase Sales Value Share by Application (2027-2032) Table 45. Global Immobilized Lipase Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 46. Global Immobilized Lipase Sales by Region (2021-2026) & (Tons) Table 47. Global Immobilized Lipase Sales Market Share by Region (2021-2026) Table 48. Global Immobilized Lipase Sales by Region (2027-2032) & (Tons) Table 49. Global Immobilized Lipase Sales Market Share by Region (2027-2032) Table 50. Global Immobilized Lipase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Immobilized Lipase Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Immobilized Lipase Sales Value Share by Region (2021-2026) Table 53. Global Immobilized Lipase Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Immobilized Lipase Sales Value Share by Region (2027-2032) Table 55. Global Immobilized Lipase Market Average Price (US$/Ton) by Region (2021-2026) Table 56. Global Immobilized Lipase Market Average Price (US$/Ton) by Region (2027-2032) Table 57. Global Immobilized Lipase Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 58. Global Immobilized Lipase Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Immobilized Lipase Sales by Country (2021-2026) & (Tons) Table 60. Global Immobilized Lipase Sales Market Share by Country (2021-2026) Table 61. Global Immobilized Lipase Sales by Country (2027-2032) & (Tons) Table 62. Global Immobilized Lipase Sales Market Share by Country (2027-2032) Table 63. Global Immobilized Lipase Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Immobilized Lipase Sales Value Market Share by Country (2021-2026) Table 65. Global Immobilized Lipase Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Immobilized Lipase Sales Value Market Share by Country (2027-2032) Table 67. Syncozymes Company Information Table 68. Syncozymes Business Overview Table 69. Syncozymes Immobilized Lipase Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Syncozymes Immobilized Lipase Product Portfolio Table 71. Syncozymes Recent Development Table 72. Yili Chuannig Biotechnology Company Information Table 73. Yili Chuannig Biotechnology Business Overview Table 74. Yili Chuannig Biotechnology Immobilized Lipase Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Yili Chuannig Biotechnology Immobilized Lipase Product Portfolio Table 76. Yili Chuannig Biotechnology Recent Development Table 77. Amicogen Company Information Table 78. Amicogen Business Overview Table 79. Amicogen Immobilized Lipase Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Amicogen Immobilized Lipase Product Portfolio Table 81. Amicogen Recent Development Table 82. ChiralVision Company Information Table 83. ChiralVision Business Overview Table 84. ChiralVision Immobilized Lipase Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. ChiralVision Immobilized Lipase Product Portfolio Table 86. ChiralVision Recent Development Table 87. Novozymes Company Information Table 88. Novozymes Business Overview Table 89. Novozymes Immobilized Lipase Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Novozymes Immobilized Lipase Product Portfolio Table 91. Novozymes Recent Development Table 92. Beijing Global Biologicals Company Information Table 93. Beijing Global Biologicals Business Overview Table 94. Beijing Global Biologicals Immobilized Lipase Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Beijing Global Biologicals Immobilized Lipase Product Portfolio Table 96. Beijing Global Biologicals Recent Development Table 97. Qingdao Weilan Bio Company Information Table 98. Qingdao Weilan Bio Business Overview Table 99. Qingdao Weilan Bio Immobilized Lipase Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Qingdao Weilan Bio Immobilized Lipase Product Portfolio Table 101. Qingdao Weilan Bio Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Immobilized Lipase Distributors List Table 105. Immobilized Lipase Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Immobilized Lipase Product Image Figure 2. Global Immobilized Lipase Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immobilized Lipase Sales Value (2021-2032) & (US$ Million) Figure 4. Global Immobilized Lipase Sales (2021-2032) & (Tons) Figure 5. Global Immobilized Lipase Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Immobilized Lipase Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Encapsulation Image Figure 10. Covalent Bonding Image Figure 11. Adsorption Image Figure 12. Cross-linking Image Figure 13. Global Immobilized Lipase Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Immobilized Lipase Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Immobilized Lipase Sales Volume Share by Type (2021-2032) Figure 16. Global Immobilized Lipase Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Immobilized Lipase Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Immobilized Lipase Sales Value Share by Type (2021-2032) Figure 19. Pharmaceuticals Image Figure 20. Food Image Figure 21. Chemicals Image Figure 22. Others Image Figure 23. Global Immobilized Lipase Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 24. Global Immobilized Lipase Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Immobilized Lipase Sales Volume Share by Application (2021-2032) Figure 26. Global Immobilized Lipase Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Immobilized Lipase Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Immobilized Lipase Sales Value Share by Application (2021-2032) Figure 29. Global Immobilized Lipase Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 30. Global Immobilized Lipase Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Immobilized Lipase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Immobilized Lipase Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Immobilized Lipase Sales Value (2021-2032) & (US$ Million) Figure 34. North America Immobilized Lipase Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Immobilized Lipase Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Immobilized Lipase Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Immobilized Lipase Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Immobilized Lipase Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Immobilized Lipase Sales Value (2021-2032) & (US$ Million) Figure 40. South America Immobilized Lipase Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Immobilized Lipase Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Immobilized Lipase Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Immobilized Lipase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Immobilized Lipase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Immobilized Lipase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Immobilized Lipase Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Immobilized Lipase Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Encapsulation
  • Covalent Bonding
  • Adsorption
  • Cross-linking
Applications
  • Pharmaceuticals
  • Food
  • Chemicals
  • Others
Companies covered
  • Syncozymes
  • Yili Chuannig Biotechnology
  • Amicogen
  • ChiralVision
  • Novozymes
  • Beijing Global Biologicals
  • Qingdao Weilan Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Immobilized Lipase Sales Value (2021-2032)
  4. 1.2.2 Global Immobilized Lipase Sales Volume (2021-2032)
  5. 1.2.3 Global Immobilized Lipase Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Immobilized Lipase Market Dynamics
  1. 2.1 Immobilized Lipase Industry Trends
  2. 2.2 Immobilized Lipase Industry Drivers
  3. 2.3 Immobilized Lipase Industry Opportunities and Challenges
  4. 2.4 Immobilized Lipase Industry Restraints
3 Immobilized Lipase Market by Company
  1. 3.1 Global Immobilized Lipase Company Revenue Ranking in 2025
  2. 3.2 Global Immobilized Lipase Revenue by Company (2021-2026)
  3. 3.3 Global Immobilized Lipase Sales Volume by Company (2021-2026)
  4. 3.4 Global Immobilized Lipase Average Price by Company (2021-2026)
  5. 3.5 Global Immobilized Lipase Company Ranking (2024-2026)
  6. 3.6 Global Immobilized Lipase Company Manufacturing Base and Headquarters
  7. 3.7 Global Immobilized Lipase Company Product Type and Application
  8. 3.8 Global Immobilized Lipase Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Immobilized Lipase Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Immobilized Lipase Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Immobilized Lipase Market by Type
  1. 4.1 Immobilized Lipase Type Introduction
  2. 4.1.1 Encapsulation
  3. 4.1.2 Covalent Bonding
  4. 4.1.3 Adsorption
  5. 4.1.4 Cross-linking
  6. 4.2 Global Immobilized Lipase Sales Volume by Type
  7. 4.2.1 Global Immobilized Lipase Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Immobilized Lipase Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Immobilized Lipase Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Immobilized Lipase Sales Value by Type
  11. 4.3.1 Global Immobilized Lipase Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Immobilized Lipase Sales Value by Type (2021-2032)
  13. 4.3.3 Global Immobilized Lipase Sales Value Share by Type (2021-2032)
5 Immobilized Lipase Market by Application
  1. 5.1 Immobilized Lipase Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Food
  4. 5.1.3 Chemicals
  5. 5.1.4 Others
  6. 5.2 Global Immobilized Lipase Sales Volume by Application
  7. 5.2.1 Global Immobilized Lipase Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Immobilized Lipase Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Immobilized Lipase Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Immobilized Lipase Sales Value by Application
  11. 5.3.1 Global Immobilized Lipase Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Immobilized Lipase Sales Value by Application (2021-2032)
  13. 5.3.3 Global Immobilized Lipase Sales Value Share by Application (2021-2032)
6 Immobilized Lipase Regional Sales and Value Analysis
  1. 6.1 Global Immobilized Lipase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immobilized Lipase Sales by Region (2021-2032)
  3. 6.2.1 Global Immobilized Lipase Sales by Region: 2021-2026
  4. 6.2.2 Global Immobilized Lipase Sales by Region (2027-2032)
  5. 6.3 Global Immobilized Lipase Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Immobilized Lipase Sales Value by Region (2021-2032)
  7. 6.4.1 Global Immobilized Lipase Sales Value by Region: 2021-2026
  8. 6.4.2 Global Immobilized Lipase Sales Value by Region (2027-2032)
  9. 6.5 Global Immobilized Lipase Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Immobilized Lipase Sales Value (2021-2032)
  12. 6.6.2 North America Immobilized Lipase Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Immobilized Lipase Sales Value (2021-2032)
  15. 6.7.2 Europe Immobilized Lipase Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Immobilized Lipase Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Immobilized Lipase Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Immobilized Lipase Sales Value (2021-2032)
  21. 6.9.2 South America Immobilized Lipase Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Immobilized Lipase Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Immobilized Lipase Sales Value Share by Country, 2025 VS 2032
7 Immobilized Lipase Country-level Sales and Value Analysis
  1. 7.1 Global Immobilized Lipase Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Immobilized Lipase Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Immobilized Lipase Sales by Country (2021-2032)
  4. 7.3.1 Global Immobilized Lipase Sales by Country (2021-2026)
  5. 7.3.2 Global Immobilized Lipase Sales by Country (2027-2032)
  6. 7.4 Global Immobilized Lipase Sales Value by Country (2021-2032)
  7. 7.4.1 Global Immobilized Lipase Sales Value by Country (2021-2026)
  8. 7.4.2 Global Immobilized Lipase Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Immobilized Lipase Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Immobilized Lipase Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Immobilized Lipase Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Immobilized Lipase Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Immobilized Lipase Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Immobilized Lipase Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Immobilized Lipase Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Immobilized Lipase Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Immobilized Lipase Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Immobilized Lipase Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Immobilized Lipase Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Immobilized Lipase Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Immobilized Lipase Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Immobilized Lipase Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Immobilized Lipase Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Immobilized Lipase Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Immobilized Lipase Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Immobilized Lipase Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Immobilized Lipase Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Immobilized Lipase Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Immobilized Lipase Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Immobilized Lipase Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Immobilized Lipase Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Immobilized Lipase Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Immobilized Lipase Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Immobilized Lipase Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Immobilized Lipase Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Immobilized Lipase Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Immobilized Lipase Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Immobilized Lipase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Syncozymes
  2. 8.1.1 Syncozymes Company Information
  3. 8.1.2 Syncozymes Business Overview
  4. 8.1.3 Syncozymes Immobilized Lipase Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Syncozymes Immobilized Lipase Product Portfolio
  6. 8.1.5 Syncozymes Recent Developments
  7. 8.2 Yili Chuannig Biotechnology
  8. 8.2.1 Yili Chuannig Biotechnology Company Information
  9. 8.2.2 Yili Chuannig Biotechnology Business Overview
  10. 8.2.3 Yili Chuannig Biotechnology Immobilized Lipase Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yili Chuannig Biotechnology Immobilized Lipase Product Portfolio
  12. 8.2.5 Yili Chuannig Biotechnology Recent Developments
  13. 8.3 Amicogen
  14. 8.3.1 Amicogen Company Information
  15. 8.3.2 Amicogen Business Overview
  16. 8.3.3 Amicogen Immobilized Lipase Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Amicogen Immobilized Lipase Product Portfolio
  18. 8.3.5 Amicogen Recent Developments
  19. 8.4 ChiralVision
  20. 8.4.1 ChiralVision Company Information
  21. 8.4.2 ChiralVision Business Overview
  22. 8.4.3 ChiralVision Immobilized Lipase Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 ChiralVision Immobilized Lipase Product Portfolio
  24. 8.4.5 ChiralVision Recent Developments
  25. 8.5 Novozymes
  26. 8.5.1 Novozymes Company Information
  27. 8.5.2 Novozymes Business Overview
  28. 8.5.3 Novozymes Immobilized Lipase Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Novozymes Immobilized Lipase Product Portfolio
  30. 8.5.5 Novozymes Recent Developments
  31. 8.6 Beijing Global Biologicals
  32. 8.6.1 Beijing Global Biologicals Company Information
  33. 8.6.2 Beijing Global Biologicals Business Overview
  34. 8.6.3 Beijing Global Biologicals Immobilized Lipase Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Beijing Global Biologicals Immobilized Lipase Product Portfolio
  36. 8.6.5 Beijing Global Biologicals Recent Developments
  37. 8.7 Qingdao Weilan Bio
  38. 8.7.1 Qingdao Weilan Bio Company Information
  39. 8.7.2 Qingdao Weilan Bio Business Overview
  40. 8.7.3 Qingdao Weilan Bio Immobilized Lipase Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Qingdao Weilan Bio Immobilized Lipase Product Portfolio
  42. 8.7.5 Qingdao Weilan Bio Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Immobilized Lipase Value Chain Analysis
  2. 9.1.1 Immobilized Lipase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Immobilized Lipase Sales Mode & Process
  6. 9.2 Immobilized Lipase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Immobilized Lipase Distributors
  9. 9.2.3 Immobilized Lipase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst